STU:8HX1 (China)
Â
Shs Sponsored American Deposit Receipt Repr 1 Sh
€
1.2
+0.030 (+2.56%)
Aug 6
Business Description
Akso Health Group
ISIN : US4282951098
Share Class Description:
STU:8HX1: Shs Sponsored American Deposit Receipt Repr 1 ShTotal Employee Number:
27Compare
Compare
Traded in other countries / regions
AHG.USA8HX1.Germany IPO Date
2018-06-29Description
Akso Health Group is a social e-commerce platform based in China. The company collaborates with domestic e-commerce platforms and offers users a wide selection of high-quality and affordable products on its social e-commerce platform. It generates majority of the revenues from sale of medical devices business.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.46 | |||||
Equity-to-Asset | 0.95 | |||||
Debt-to-EBITDA | -0.23 | |||||
Interest Coverage | N/A |
N/A
|
N/A
| |||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | 85.4 | |||||
Beneish M-Score | 8.71 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -67.9 | |||||
3-Year EBITDA Growth Rate | 85.3 | |||||
3-Year EPS without NRI Growth Rate | 75.8 | |||||
3-Year FCF Growth Rate | -22.5 | |||||
3-Year Book Growth Rate | -18 |
Momentum Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 40.63 | |||||
9-Day RSI | 43.61 | |||||
14-Day RSI | 45.68 | |||||
3-1 Month Momentum % | -32.22 | |||||
6-1 Month Momentum % | 2.52 | |||||
12-1 Month Momentum % | -12.23 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 21.77 | |||||
Quick Ratio | 21.74 | |||||
Cash Ratio | 0.02 | |||||
Days Inventory | 5.13 | |||||
Days Sales Outstanding | 47.54 | |||||
Days Payable | 6.86 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -234.6 | |||||
Shareholder Yield % | 0.18 |
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | -0.08 | |||||
Operating Margin % | -28.92 | |||||
Net Margin % | -134.99 | |||||
EBITDA Margin % | -11.78 | |||||
FCF Margin % | -1353.79 | |||||
OCF Margin % | -93.32 | |||||
ROE % | -9.69 | |||||
ROA % | -9.08 | |||||
ROIC % | -2.57 | |||||
3-Year ROIIC % | 5.8 | |||||
ROC (Joel Greenblatt) % | -3.36 | |||||
ROCE % | -2.06 | |||||
Years of Profitability over Past 10-Year | 3 | |||||
Moat Score | 3 | |||||
Tariff Resilience Score | 5 |
GF Value Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PS Ratio | 74.87 | |||||
PB Ratio | 7.1 | |||||
Price-to-Tangible-Book | 7.06 | |||||
EV-to-EBIT | -312.75 | |||||
EV-to-Forward-EBIT | 0.28 | |||||
EV-to-EBITDA | -767.94 | |||||
EV-to-Revenue | 90.44 | |||||
EV-to-Forward-Revenue | 0.13 | |||||
EV-to-FCF | -6.64 | |||||
Price-to-GF-Value | 3.75 | |||||
| Price-to-Net-Current-Asset-Value | 7.06 | |||||
Earnings Yield (Greenblatt) % | -0.32 | |||||
FCF Yield % | -15.07 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Akso Health Group Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 11.874 | ||
| EPS (TTM) (€) | -0.026 | ||
| Beta | -6.3312 | ||
| 3-Year Sharpe Ratio | 0.81 | ||
| 3-Year Sortino Ratio | 2.81 | ||
| Volatility % | 74.52 | ||
| 14-Day RSI | 45.68 | ||
| 14-Day ATR (€) | 0.09536 | ||
| 20-Day SMA (€) | 1.24 | ||
| 12-1 Month Momentum % | -12.23 | ||
| 52-Week Range (€) | 0.71 - 2.14 | ||
| Shares Outstanding (Mil) | 856.7 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Akso Health Group Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Akso Health Group Stock Events
| Event | Date | Price (€) | ||
|---|---|---|---|---|
| Second quarter earnings results for 2027 | 2026-11-13 | In 98 days | ||
| General meeting for 2026 | 2026-08-21 | In 14 days | ||
| First quarter earnings results for 2027 | 2026-08-20 | In 13 days | ||
| Annual report for 2026 | 2026-07-27 | 1.26 (+0.00%) | ||
| Annual report for 2025 | 2025-08-14 | 1.55 (+0.00%) | ||
| 0.333333:1 Stock Split | 2020-08-24 | 2.18 (-1.36%) |
Show
Entries
Akso Health Group Frequently Asked Questions
What is Akso Health Group(STU:8HX1)'s stock price today?
The current price of STU:8HX1 is €1.20. The 52 week high of STU:8HX1 is €2.14 and 52 week low is €0.71.
When is next earnings date of Akso Health Group(STU:8HX1)?
The next earnings date of Akso Health Group(STU:8HX1) is 2026-08-20 Est..
Does Akso Health Group(STU:8HX1) pay dividends? If so, how much?
Akso Health Group(STU:8HX1) does not pay dividend.
Press Release
Articles on Akso Health Group
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers